Diagnostic and therapeutic aspects of receptor-mediated leukemogenesis
US4786590A · kind A · utility
4Cited by
5References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 15, 1985 |
| Grant date | Nov 22, 1988 |
| Priority date | — |
| Expiry date | Jan 15, 2005 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/813
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Specific binding members are provided for binding to lymphocytic cell surface receptors, which receptors are involved in the activation of a cell from the G.sub.0 state into the cell division cycle to proliferate. The cell surface receptors are further characterized by binding to envelope proteins of neoplasia-causing retroviruses, and/or to intact retroviral particles.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.